- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06077526
Alleviating Burden of Chronic Musculoskeletal Pain in the Emergency Department
Alleviating Burden of Chronic Musculoskeletal Pain in the Emergency Department: P.E.A.K. Rx Feasibility Trial
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michael Ray, DC, MSc
- Phone Number: 540-828-5416
- Email: bray@bridgewater.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older
- Sedentary (e.g., not meeting PA guidelines, assessed by ACSM PA vitals)
- English speaking and reading comprehension
- Not currently pregnant
Diagnosed with CMP based on electronic health record:
- Non-red flag presentation (e.g., red flags: current fracture, malignancy, infection, vascular issues, or in need of surgical intervention).
- Persistent or recurrent pain for 3+ months, with at least moderate pain intensity level (Visual Analog Scale of 40/100)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control - Usual Care
Group B will receive the community hospital's usual care.
|
Participants will receive the community hospital's usual care.
|
|
Experimental: Experimental - P.E.A.K. Rx
Group A intervention, P.E.A.K. Rx, will be supervised and directed by healthcare clinicians, known as Pain Coaches.
P.E.A.K. Rx will involve 2 meetings per week of pain education + physical activity.
|
Pain Education + Physical Activity Group Based Intervention
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale
Time Frame: Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
Quantitative metric of an individual's pain on a numerical scale. Scores range from 0 - 100, where 0 means no pain and 100 means maximum pain. 1-30 = mild 31-69 = moderate 70-100 = severe MCID of 12 point change [60]. |
Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tampa Scale of Kinesiophobia
Time Frame: Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
Quantitative metric asking 17 questions using a 4-point Likert scale regarding a participant's fear and avoidance of movement.
Scores range from 17 to 68, where 17 means no kinesiophobia and higher scores indicate increasing severity of kinesiophobia.
Scores ≥ 37 indicate kinesiophobia.
MCID of 7.5-9 points [61].
|
Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
|
Pain Catastrophizing Scale
Time Frame: Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
13-item quantitative metric assessing participant's catastrophic thinking about their pain experience, contributing to rumination, magnification, and learned helplessness. Utilizes 4-item scale to assess frequency of particular thoughts, 0 = not at all to 4 = all the time. Total score ranges from 0 - 52. Score ≥ 30 indicates catastrophizing. MCID of 11 points for those considered to be engaging in catastrophic thinking (baseline score >30 points) [62]. |
Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
|
Patient Specific Functional Scale (PSFS)
Time Frame: Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
Assesses impact of pain on participant's function by identification of difficult or unable to perform activities. 11-point Likert scale ranks participant's current level of difficulty for each activity (0 = unable to perform, 10 = able to perform activity at same level before injury or problem). Assess improvement in function of valued activities post intervention. MCID is categorized: Small change = 1.3 Medium change = 2.3 Large change = 2.7 [63]. |
Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
|
Saltin-Grimby physical activity scale for leisure time physical activity
Time Frame: Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
Assesses participants perception of their leisure time activities. Describe your exercise and physical exertion in leisure time. If your activity varies much, for example between summer and winter, then give an average. The question refers only to the last year. Four different levels: "Reading, watching TV, or other sedentary activity," "Walking, cycling, or other forms of exercise at least 4 hours a week (here including walking or cycling to place of work, Sunday walking, etc.)," "Participation in recreational sports, heavy gardening, etc. (note: duration of activity at least 4 hours a week)" and "Participation in hard training or sports competitions, regularly several times a week." 4 levels renamed: "inactive," "low," "moderate," and "vigorous," respectively [65] |
Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
|
36-Item Short Form Health Survey (SF-36)
Time Frame: Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
A health-related quality of life survey assessing eight dimensions: physical function, role limitations due to physical health problems, bodily pain, general health, vitality, social functioning, role limitation due to emotional problems, and mental health.
Scores for each dimension range from 0 (worst level of functioning) to 100 (best level of functioning).
Total sore MCID of 4.6 points [64].
|
Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
|
Self-report physical exercise
Time Frame: Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
Exercise assessment through 3 questions on frequency, duration, and intensity, where the respondents will be asked to estimate their weekly average. Frequency question: "How often do you exercise (i.e., walking, skiing, swimming or training/sports)?" Duration question: "For how long (time) do you exercise?" Intensity question "If you exercise-how hard do you exercise?" Frequency categories: "never", "less than once a week", "once a week", "2 to 3 times a week", or "approximately every day". Duration categories: "less than 15 minutes", "15 to 29 minutes", "30 to 60 minutes", or "more than 1 hour." Intensity categories: "Easy-you do not become short-winded or sweaty", "You become short-winded and sweaty", and "Hard-you become exhausted". Categorized as "low", "moderate", and "hard" respectively [65]. |
Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
|
Self-report occupational activity
Time Frame: Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
Assess occupational physical activity. Question: "If you have paid or unpaid work, which statement describes your work best? Response categories: "mostly sedentary work (e.g., office work)", "work that requires a lot of walking (e.g., shop assistant, light industrial work)", and "work that requires a lot of walking and lifting (e.g., nursing, construction, or heavy manual labor)". |
Baseline, post-intervention 8-weeks, 3-months, and 6-months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Ray, DC, MSc, Bridgewater College
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
University Rovira i VirgiliMinisterio de Ciencia e Innovación, SpainNot yet recruitingChronic Post-operative Pain | Chronic Postsurgical Pain | Chronic Post-surgical Pain | Chronic Postoperative PainSpain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Bjorn AngKarolinska Institutet; The Swedish Research Council; Göteborg University; Forte; Dalarna...Not yet recruitingPain Management | Pain, Chronic | Chronic Pain, WidespreadSweden
-
Washington D.C. Veterans Affairs Medical CenterRecruitingChronic Back Pain | Chronic Pain (back / Neck)United States
-
The University of Texas Health Science Center,...RecruitingJoint Pain | Chronic Knee Pain | Chronic Pain (Back / Neck) | Chronic Pain ManagementUnited States
-
University of FaisalabadNot yet recruiting
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
Universidade do Vale do ParaíbaCAPES Foundation - Ministry of Education, Brazil.Enrolling by invitationChronic Low Back Pain | Chronic Shoulder Pain | Chronic Knee PainBrazil
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Massachusetts General HospitalCompletedChronic Low Back Pain | Chronic Neck PainUnited States
Clinical Trials on P.E.A.K. Rx
-
Abbott Medical DevicesCompletedCarotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy (CANOPY)Stroke | Carotid Artery Disease | Amaurosis Fugax | Transient Ischemic Attack (TIA)United States
-
Abbott Medical DevicesCompleted
-
Atrium Medical CorporationCompletedHypertension, Renovascular | Renal Artery StenosisUnited States
-
Abbott Medical DevicesCompleted
-
Unity Health TorontoCompletedMCI | Amnestic Mild Cognitive DisorderCanada
-
Processa PharmaceuticalsCompletedSolid Tumor | Metastatic Bladder CancerUnited States
-
Kaiser PermanenteUnity HealthActive, not recruitingPhysical Activity | Mental Health Wellness 1United States
-
University Hospital, GhentCompletedReplacement | ACL RuptureBelgium